Table 3.

Patient demographics, biopsy results and management plans for patients managed with local anaesthetic transperineal biopsy during the COVID‐19 pandemic.

Patient demographics
Total number of patients	16
Median (range) age, years	60 (46–68)
Median PSA, ng/mL	10.3
Median PSA density, ng/mL/cc	0.26
Median Likert score	4
Results
Median number of cores taken	16
Benign, n (%)	5 (38)
ISUP 1, n (%)	1 (8)
ISUP ≥2, n (%)	10 (63)
ISUP ≥3, n (%)	4 (25)
Management plans, n (%)
MDT decision pending	3 (19)
Discharged	5 (31)
Active surveillance	1 (6)
Not for hormones, active treatment after COVID‐19	4 (25)
Bicalutamide initially, consider active treatment after COVID‐19	3 (19)

ISUP, International Society of Urological Pathology; MDT, multidisciplinary team.